The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Systemic levels of the soluble co-inhibitory immune checkpoints, CTLA-4, LAG-3, PD-1/PD-L1, and TIM-3 are markedly increased in basal cell carcinoma.
 
Bernardo Leon Rapoport
Honoraria - Janssen; Lilly; MSD; Novartis South Africa
Consulting or Advisory Role - Janssen; Lilly; Novartis South Africa
Speakers' Bureau - Amgen; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; ECS Progastrin; Janssen; Lilly; Merck; Mylan; Novartis South Africa; Roche
Research Funding - Cancer Association of South Africa; ECS Progastrin; GlaxoSmithKline; HalioDx; Roche; Sandoz
 
Nonkululeko Malinga
No Relationships to Disclose
 
Shalete Siwele
No Relationships to Disclose
 
Helen C. Steel
No Relationships to Disclose
 
Luyanda LI Kwofie
No Relationships to Disclose
 
Pieter Meyer
No Relationships to Disclose
 
Teresa Smit
No Relationships to Disclose
 
Ronald Anderson
No Relationships to Disclose
 
Mahlatse Kgokolo
No Relationships to Disclose